The expression of intermediate filament protein nestin and its association with cyclin-dependent kinase 5 in the glomeruli of rats with diabetic nephropathy

American Journal of the Medical Sciences

Volumn 345, Issue 6, 2013, Pages 470-477

  Liu, Wei ^a   Zhang, Yue ^a   Liu, Shuxia ^a   Liu, Qingjuan ^a   Hao, Jun ^a   Shi, Yonghong ^a   Zhao, Song ^a   Duan, Huijun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Cyclin dependent kinase 5; Diabetic nephropathy; Nestin; Roscovitine; Vimentin

Indexed keywords

CYCLIN DEPENDENT KINASE 5; MESSENGER RNA; NESTIN; ROSCOVITINE; STREPTOZOCIN; VIMENTIN;

ALBUMINURIA; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLOMERULUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KIDNEY PARENCHYMA; MALE; MICROSCOPY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

EID: 84878431008     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3182648459     Document Type: Conference Paper

References (42)

1. Menini S, Iacobini C, Oddi G, et al. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease. Diabetologia 2007;50:2591-9.
2. Reidy K, Susztak K. Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease. Am J Kidney Dis 2009;54:590-3.
3. Yamaguchi Y, Lwano M, Suzuki D, et al. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis 2009;54:653-64.
4. Miyauchi M, Toyoda M, Kobayashi K, et al. Hypertrophy and loss of podocytes in diabetic nephropathy. Intern Med 2009;48:1615-20.
5. Fuchshofer R, Ullmann S, Zeilbeck LF, et al. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury. Histochem Cell Biol 2011;136:301-19.
6. Miao J, Fan Q, Cui Q, et al. Newly identified cytoskeletal components are associated with dynamic changes of podocyte foot processes. Nephrol Dial Transplant 2009;24:3297-305.
7. Hsu HH, Hoffmann S, Endlich N, et al. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J MolMed (Berl) 2008;86:1379-94.
8. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990;60:585-95.
9. Hunziker E, Stein M. Nestin-expressing cells in the pancreatic islets of Langerhans. Biochem Biophys Res Commun 2000;271:116-9.
10. Kachinsky AM, Dominov JA, Miller JB. Myogenesis and the intermediate filament protein, nestin. Dev Biol 1994;165:216-28.
11. Kachinsky AM, Dominov JA, Miller JB. Intermediate filaments in cardiac myogenesis: nestin in the developing mouse heart. J Histochem Cytochem 1995;43:843-7.
12. Li L, Mignone J, Yang M, et al. Nestin expression in hair follicle sheath progenitor cells. Proc Natl Acad Sci U S A 2003;100:9958-61.
13. Chen J, Boyle S, Zhao M, et al. Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes. J Am Soc Nephrol 2006;17:1283-91.
14. Bertelli E, Regoli M, Fonzi L, et al. Nestin expression in adult and developing human kidney. J Histochem Cytochem 2007;55:411-21.
15. Su W, Chen J, Yang H, et al. Expression of nestin in the podocytes of normal and diseased human kidneys. Am J Physiol Regul Integr Comp Physiol 2007;292:R1761-7.
16. Dhavan R, Tsai LH. A decade of CDK5. Nat Rev Mol Cell Biol 2001; 2:749-59.
17. Sahlgren CM, Mikhailov A, Vaittinen S, et al. Cdk5 regulates the organization of Nestin and its association with p35. Mol Cell Biol 2003; 23:5090-106.
18. Sahlgren CM, Pallari HM, He T, et al. A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death. EMBO J 2006;25: 4808-19.
19. Pippin JW, Qu Q, Meijer L, et al. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist. J Clin Invest 1997;100:2512-20.
20. Ishimura E, Sterzel RB, Budde K, et al. Formation of extracellular matrix by cultured rat mesangial cells. Am J Pathol 1989;134:843-55.
21. Ohse T, Pippin JW, Vaughan MR, et al. Establishment of conditionally immortalized mouse glomerular parietal epithelial cells in culture. J Am Soc Nephrol 2008;19:1879-90.
22. de Zeeuw D, Remuzzi G, Parving HH, et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004;65:2309-20.
23. Steffes MW, Schmidt D, McCrery R, et al. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 2001;59:2104-13.
24. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997;99:342-48.
25. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts longterm urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 1999;42:1341-4.
26. Dalla Vestra M, Masiero A, Roiter AM, et al. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 2003;52:1031-5.
27. Peters I, Tossidou I, Achenbach J, et al. IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes. J Am Soc Nephrol 2006;17:1644-56.
28. Bijian K, Takano T, Papillon J, et al. Actin cytoskeleton regulates extracellular matrix-dependent survival signals in glomerular epithelial cells. Am J Physiol Renal Physiol 2005;289:F1313-23.
29. Fuchs E, Cleveland DW. A structural scaffolding of intermediate filaments in health and disease. Science 1998;279:514-9.
30. Russo LM, Sandoval RM, Campos SB, et al. Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J Am Soc Nephrol 2009;20:489-94.
31. Russo LM, del Re E, Brown D, et al. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor. Diabetes 2007;56:380-8.
32. Zou J, Yaoita E, Watanabe Y, et al. Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch 2006; 448:485-92.
33. Xu ZG, Yoo TH, Ryu DR, et al. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli. Kidney Int 2005;67:944-52.
34. Petermann AT, Pippin J, Durvasula R, et al. Mechanical stretch induces podocyte hypertrophy in vitro. Kidney Int 2005;67:157-66.
35. Wagner N, Wagner KD, Scholz H, et al. Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1. Am J Physiol Regul Integr Comp Physiol 2006;291:779-87.
36. Hellmich MR, Pant HC, Wada E, et al. Neuronal cdc2-like kinase: a cdc2-related protein kinase with predominantly neuronal expression. Proc Natl Acad Sci U S A 1992;89:10867-71.
37. Pallari HM, Lindqvist J, Torvaldson E, et al. Nestin as a regulator of Cdk5 in differentiating myoblasts. Mol Biol Cell 2011;22:1539-49.
38. Griffin SV, Hiromura K, Pippin J, et al. Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology. Am J Pathol 2004;165:1175-85.
39. Lilja L, Johansson JU, Gromada J, et al. Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca(2+)-dependent exocytosis. J Biol Chem 2004;279:29534-41.
40. Wei FY, Nagashima K, Ohshima T, et al. Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nat Med 2005;11:1104-8.
41. Okada S, Yamada E, Saito T, et al. CDK5-dependent phosphorylation of the Rho family GTPase TC10(alpha) regulates insulin-stimulated GLUT4 translocation. J Biol Chem 2008;283:35455-63.
42. Lalioti V, Muruais G, Dinarina A, et al. The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 2009;106:4249-53.